Esoteric Tests Coding and Billing

Home/Expert Witness/Pathology Lab Test Expert Witness/Esoteric Tests Coding and Billing
Esoteric Tests Coding and Billing 2017-05-04T04:05:57+00:00

What do we do regarding esoteric tests expert witness work?

esoteric tests expert witness

Michael Arrigo expert witness in Federal State and Civil Courts on ACA, HIPAA, Healthcare costs in malpractice and personal injury, False Claims Act cases involving Medicare Advantage and Electronic Health Records.  CONTACT

The esoteric tests expert witness work regarding coding and billing includes reviewing the test charge amounts versus national and regional charge averages, evaluating MUEs which are “Medically Unlikely Edits” as well as the cost of care based on national and regional rates.  In states where the standard allows experts to provide opinions on net reimbursement rates, 50th, 75th, and 90th percentile data may be presented.  Determining usual customary and reasonable costs for esoteric tests or any new area of medicine requires careful research to find data that represents the market rates in a specified A Core Based Statistical Area (CBSA). A CBSA is a U.S. geographic area defined by the Office of Management and Budget (OMB) that consists of one or more counties (or equivalents) anchored by an urban center of at least 10,000 people plus adjacent counties that are socioeconomically tied to the urban center by commuting..  Identification of providers who perform the tests in a similar time frame and setting may also be relevant.  Also, national correct coding initiative algorithms may be used to evaluate the tests versus national coverage determination and local coverage determination policies.

What is Esoteric Testing?

The analysis of ‘rare’ substances or molecules that are not performed in a routine clinical lab. Esoteric tests are the analysis of unique, “niche” assays not routinely performed in clinical laboratories as they often require specialized personnel. Some of these tests have been or are currently being analyzed using RIA (radioimmunoassay) technique which is both costly and time consuming.   All laboratories will benefit from volume increases due to both population growth and the aging population, an increase in the number of tests per patient, and an increase in esoteric and genomic tests which are part of the trend to customize treatments.  

Categories of Esoteric Test

Esoteric tests are generally considered to include Biochemical Genetics, Cytogenetics/FISH, Flow Cytometry, Microbiology, Molecular Genetic Pathology, RBC, Special Studies, Special Coagulation, and Virology.

See also our page regarding expert witness services for pathology coding and billing.

esoteric test opinions

Tests including: Biochemical Genetics, Cytogenetics/FISH, Flow Cytometry, Microbiology, Molecular Genetic Pathology, RBC, Special Studies, Special Coagulation, Virology
CategoryDescriptionAbbrev CodeCPT
Red Blood Cell (RBC) Special Studies LaboratoryADENOSINE DEAMINASE (ADA), BLOOD, QUANTITATIVEADAQ82657
Red Blood Cell (RBC) Special Studies LaboratoryEMA (EOSIN-5-MALEIMIDE) BY FLOW CYTOMETRYEMA
Red Blood Cell (RBC) Special Studies LaboratoryGLUCOSE-6-PHOSPHATE DEHYDROGENASE, QUANTITATIVE, WHOLE BLOODG6PDQT
Red Blood Cell (RBC) Special Studies LaboratoryHEMOGLOBIN F QUANTITATIVEHGBFQ
Red Blood Cell (RBC) Special Studies LaboratoryHEMOGLOBIN QUANTITATION / FRACTIONATION BY CAPILLARY ZONE ELECTROPHORESISHGBQ
Red Blood Cell (RBC) Special Studies LaboratoryHEMOGLOBIN S QUANTITATIVEHGBSQ
Red Blood Cell (RBC) Special Studies LaboratoryOSMOTIC FRAGILITY, RBCOF
Red Blood Cell (RBC) Special Studies LaboratoryPURINE NUCLEOSIDE PHOSPHORYLASE (PNP) QUANTITATIVEPNPQ
Red Blood Cell (RBC) Special Studies LaboratoryRBC ENZYME PANELRBCENZ
Metabolic diseases : defects in the biochemical pathways of amino acids, organic acids, fatty acids and carbohydrates. ACYLCARNITINE PROFILE, QUANTITATIVEACYLP82017
Metabolic diseases : defects in the biochemical pathways of amino acids, organic acids, fatty acids and carbohydrates. AMINO ACIDS, BLOOD SPOTAABS
Metabolic diseases : defects in the biochemical pathways of amino acids, organic acids, fatty acids and carbohydrates. AMINO ACIDS, QUANTITATIVE, CSFAACSF
Metabolic diseases : defects in the biochemical pathways of amino acids, organic acids, fatty acids and carbohydrates. AMINO ACIDS, QUANTITATIVE, PLASMAAAP
Metabolic diseases : defects in the biochemical pathways of amino acids, organic acids, fatty acids and carbohydrates. AMINO ACIDS, QUANTITATIVE, URINEAAUR
Metabolic diseases : defects in the biochemical pathways of amino acids, organic acids, fatty acids and carbohydrates. BIOTINIDASEBTDASE
Metabolic diseases : defects in the biochemical pathways of amino acids, organic acids, fatty acids and carbohydrates. BRANCHED CHAIN AMINO ACIDSBCAA
Metabolic diseases : defects in the biochemical pathways of amino acids, organic acids, fatty acids and carbohydrates. CARNITINE, FREE AND TOTAL, PLASMA/SERUMCARN
Metabolic diseases : defects in the biochemical pathways of amino acids, organic acids, fatty acids and carbohydrates. CARNITINE, FREE AND TOTAL, URINEUCARN
Metabolic diseases : defects in the biochemical pathways of amino acids, organic acids, fatty acids and carbohydrates. METHYLMALONIC ACID, SERUMMMAS
Metabolic diseases : defects in the biochemical pathways of amino acids, organic acids, fatty acids and carbohydrates. MUCOPOLYSACCHARIDES, TLC, URINEMPSTLC
Metabolic diseases : defects in the biochemical pathways of amino acids, organic acids, fatty acids and carbohydrates. MUCOPOLYSACCHARIDES, URINE, QUANTITATIVEMPSQNT
Metabolic diseases : defects in the biochemical pathways of amino acids, organic acids, fatty acids and carbohydrates. OLIGOSACCHARIDES, TLC, URINEOSTLC
Metabolic diseases : defects in the biochemical pathways of amino acids, organic acids, fatty acids and carbohydrates. ORGANIC ACIDS, QUALITATIVE, URINEUORG
Metabolic diseases : defects in the biochemical pathways of amino acids, organic acids, fatty acids and carbohydrates. OROTIC ACID, URINEUOROT
Metabolic diseases : defects in the biochemical pathways of amino acids, organic acids, fatty acids and carbohydrates. PHENYLALANINE AND TYROSINEPHATYR
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)13Q, FISHCGFi 13Q88271 x 2, 88275
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)1P/19Q DELETIONS IN OLIGODENDROGLIOMAFISH GLIOMA
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)4P- SYNDROME (WOLF-HIRSCHHORN SYNDROME), 4P16.3CGF MCDEL
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)5P- SYNDROME (CRI DU CHAT SYNDROME), 5P15.2CGF MCDEL
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)5Q, FISHCGFi 5Q
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)7Q, FISHCGFi 7Q
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)ALK GENE REARRANGEMENTFISH ALK
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)ANGELMAN SYNDROME (AS), 15Q11.2 (D15S10 DELETION)CGF ANGLM
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)ARRAY COMPARATIVE GENOMIC HYBRIDIZATION (ACGH)CGH GEN
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)BCL2 GENE REARRANGEMENT IN FOLLICULAR LYMPHOMA (FISH BCL2 )FISH BCL2
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)BCL6, FISHCGFi BCL6
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)BCR/ABL GENE FUSION IN CML AND ALL, T(9;22)(Q34;Q11.2)CGFi BCR
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)CCND1 GENE REARRANGEMENT (FFPE)FISH CCND1
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)CCND1/IGH GENE FUSION IN MANTLE CELL LYMPHOMA, T(11;14)(Q13;Q32)CGFi MCL
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)CENTROMERE PROBES (CROSS SEX TRANSPLANT; ANAUPLOIDY)CGFi ENUM
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)CHROM. #1 COPY NUMBERCGFi 1Q1P
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)CHROMOSOME SPECIFIC SUBTELOMERIC PROBESCGF MAR
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)CLL PANEL (+12, 11Q AND 13Q DELETION, 17P DELETION) [PERIPHERAL BLOOD PREFERRED]CGFi CLL
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)CYTOGENETIC STUDY - AMNIOTIC FLUIDCG AMNIO
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)CYTOGENETIC STUDY, BLOOD (CANCER DX.)CG BLD NEO
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)CYTOGENETIC STUDY, BLOOD, HIGH RESOLUTIONCG HI RES
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)CYTOGENETIC STUDY, BLOOD, ROUTINE / PERCUTANEOUS UMBILICAL BLOOD SAMPLING (PUBS)CG BLOOD
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)CYTOGENETIC STUDY, BONE MARROWCG BONE MRW
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)CYTOGENETIC STUDY, CHORIONIC VILLICG CVS
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)CYTOGENETIC STUDY, CHROMOSOME BREAKAGE FOR ATAXIA TELANGIECTASIACG ATAXIA
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)CYTOGENETIC STUDY, CHROMOSOME BREAKAGE FOR FANCONI ANEMIACG FANCONI
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)CYTOGENETIC STUDY, TISSUE, POCCG TISS POC
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)CYTOGENETIC STUDY, TISSUE, SKIN/OTHERCG TISS SKIN
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)CYTOGENETIC STUDY, TUMORCG TUMOR
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)DIGEORGE SEQUENCE/VELOCARDIOFACIAL SYNDROME (VCF), 22Q11.2 (TUPLE1 DELETION) AND DISTAL 22Q13.3 DELETION (ARSA)CGF VCF
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)EGFR GENE AMPLIFICATIONFISH EGFR
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)ETV6/RUNX1, FISHCGFi TEL
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)EWS GENE REARRANGEMENT IN EWING SARCOMA/PNETFISH EWS
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)FGFR1 GENE REARRANGEMENTCGFi FGFR1
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)FISH CHIC 2; DELETION (OR FIP1L1/PDGFRA FUSION) IN HES AND SMCDCGFi CHIC2
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)FLUORESCENCE IN SITU HYBRIDIZATION (FISH) TESTING, PRENATAL PANELCGF PRENAT
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)FOXO1 GENE REARRANGEMENT IN ALVEOLAR RHABDOMYOSARCOMAFISH ARM
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)FUS GENE REARRANGEMENTFISH FUS
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)HER2 AMPLIFICATION BY FISHFISH HER2
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)IGH GENE REARRANGEMENTCGFi IGH
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)IGH/BCL2, FISHCGFi FCL
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)IGH/FGFR3, FISHCGFi t(4;14)
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)IGH/MAF, FISHCGFi t(14;16)
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)INV(16) FISHCGFi inv(16)
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)MAR/DEL 1-3, FISHCGF MAR
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)MDM2 GENE AMPLIFICATIONFISH MDM2
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)MDS PANEL, FISHCGFi MDSpan
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)MILLER-DIEKER SYNDROME (MDS), 17P13.3 (LIS1 DELETION)CGF MDK
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)MLL GENE REARRANGEMENT, 11Q23, IN AML AND ALLCGFi MLL
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)MYB GENE REARRANGEMENTFISH MYB
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)MYC GENE REARRANGEMENT IN BURKITT, OTHER LYMPHOMAFISH MYC
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)MYC, FISHCGFi cMYC
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)MYELOMA PANEL, FISHCGFi MMpan
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)P53, FISHCGFi P53
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)PML/RARA GENE FUSION IN APL, T(15;17)(Q22;Q21)CGFi APL
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)PRADER-WILLI SYNDROME (PWS), 15Q11.2 (SNRPN DELETION)CGF PWS
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)PRENATAL FISH FOR TRISOMIES 13, 18 AND 21, X AND Y CHROMOSOMES (5-10 ML DIRECT AMNIOTIC FLUID)CGF PRENAT
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)ROS1 GENE REARRANGEMENTFISH ROS1
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)SMITH-MAGENIS SYNDROME (SMS), 17P11.2 (FL1 DELETION)CGF SMS
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)SUBTELOMERIC FISH STUDIES FOR CRYPTIC REARRANGEMENTSCGF SUBTL
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)SYT GENE REARRANGEMENT IN SYNOVIAL SARCOMAFISH SYN SARC
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)T(8;21), FISHCGFi t(8;21)
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)TRISOMY 8CGFi ENUM
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)UROVYSION FLUORESCENCE IN SITU HYBRIDIZATION (FISH) SCREENING RECURRENT BLADDER CANCERCGFi UROV
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)WHOLE CHROMOSOME PAINTS (TO IDENTIFY UNKNOWN REARRANGEMENTS/MARKERS)CGF WCPan
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)WILLIAMS SYNDROME (WS), 7Q11.23 (WSCR DELETION)CGF WMS
Standard chromosomal (or cytogenetic) analyses performed on tissues, and Fluorescence in situ hybridization (FISH)X-LINKED ICHTHYOSIS, XP22.3 (STEROID SULFATASE DELETION)CGF MCDEL
Virology typically includes a range of culture, antigen and molecular test procedures for the diagnosis of viral and chlamydia infectionsADENOVIRUS QUANTITATIVE PCR, PLASMA ORDERADVQT87799
Virology typically includes a range of culture, antigen and molecular test procedures for the diagnosis of viral and chlamydia infectionsBK VIRUS DNA PCR PLASMA, QUANTITATIVEBKVPC
Virology typically includes a range of culture, antigen and molecular test procedures for the diagnosis of viral and chlamydia infectionsBK VIRUS DNA PCR URINE, QUANTITATIVEBKVPCU
Virology typically includes a range of culture, antigen and molecular test procedures for the diagnosis of viral and chlamydia infectionsCHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (GC), NUCLIEC ACID AMPLIFICATION TESTING (NAAT)CLGC3
Virology typically includes a range of culture, antigen and molecular test procedures for the diagnosis of viral and chlamydia infectionsCYTOMEGALOVIRUS QUANTITATIVE (CMV VIRAL LOAD) PCRCMVQT
Virology typically includes a range of culture, antigen and molecular test procedures for the diagnosis of viral and chlamydia infectionsCYTOMEGALOVIRUS(CMV) DNA, QUALITATIVE PCR, NON-PLASMACMVQL
Virology typically includes a range of culture, antigen and molecular test procedures for the diagnosis of viral and chlamydia infectionsEPSTEIN BARR VIRUS (EBV) QUANTITATIVE PCR, PLASMAEBVQP
Virology typically includes a range of culture, antigen and molecular test procedures for the diagnosis of viral and chlamydia infectionsHEPATITIS B PCR QUANTITATIVE, SERUMHBPCR
Virology typically includes a range of culture, antigen and molecular test procedures for the diagnosis of viral and chlamydia infectionsHEPATITIS C VIRUS (HCV) RNA, QUANTITATIVE PCR, SERUM, WITH REFLEX TO GENOTYPINGHCVPCX
Virology typically includes a range of culture, antigen and molecular test procedures for the diagnosis of viral and chlamydia infectionsHHV-6 QUANTITATIVE PCR, PLASMA ORDERHHV6QT
Virology typically includes a range of culture, antigen and molecular test procedures for the diagnosis of viral and chlamydia infectionsHIV-1 ANTIVIRAL RESISTANCE TESTING - INTEGRASEAVIN
Virology typically includes a range of culture, antigen and molecular test procedures for the diagnosis of viral and chlamydia infectionsHIV-1 ANTIVIRAL RESISTANCE TESTING, PROTEASE AND REVERSE-TRANSCRIPTASE, PLASMAAVRT
Virology typically includes a range of culture, antigen and molecular test procedures for the diagnosis of viral and chlamydia infectionsHIV-1 RNA, QUANTITATIVE PCR, PLASMAHIVPCR
Virology typically includes a range of culture, antigen and molecular test procedures for the diagnosis of viral and chlamydia infectionsHPV 16/18 TYPINGHPVPCR
Virology typically includes a range of culture, antigen and molecular test procedures for the diagnosis of viral and chlamydia infectionsHPV 6/11 TYPINGHPV6PC
Virology typically includes a range of culture, antigen and molecular test procedures for the diagnosis of viral and chlamydia infectionsHUMAN PAPILLOMAVIRUS VIRUS (HPV), NUCLIEC ACID AMPLIFICATION TESTING (NAAT)HPVHR3
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. A/HYPOCHONDROPLASIA, BLOODCHON81401
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. A/HYPOCHONDROPLASIA, NON-BLOODFCHON
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. ALPHA THALASSEMIA, BLOODATHAL
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. ALPHA THALASSEMIA, NON-BLOODFATHAL
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. AML PROGNOSIS ASSAY, BLOODAMLP
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. AML PROGNOSIS ASSAY, NON-BLOODBMAML
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. B-CELL CLONALITY BY PCR ,BLOODBCLON
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. B-CELL CLONALITY, NON-BLOODBMBCLO
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. BCR-ABL KINASE DOMAIN MUTATION ANALYSIS, BLOODBCRKDM
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. BCR-ABL KINASE DOMAIN MUTATION ANALYSIS, NON-BLOODNBCRKDM
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. BCR-ABL, BLOODBCRQT
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. BCR-ABL, NON-BLOODBMBCRQ
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. BETA THALASSEMIA SEQUENCING, BLOODBTHSQ
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. BETA THALASSEMIA SEQUENCING, NON-BLOODFBTHSQ
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. BIOTINIDASE SEQUENCING ASSAYBIOSA
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. BRAF, BLOODBRAF
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. BRAF, NON-BLOODNBRAF
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. CALRETICULIN MUTATION DETECTION, BLOODCALR
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. CALRETICULIN MUTATION DETECTION, NON-BLOODNCALR
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. CANCER SOMATIC MUTATION PANEL, BLOODCSMPB
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. CANCER SOMATIC MUTATION PANEL, NON-BLOODCSMP
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. CDH1 BY SEQUENCING (FAMILIAL GASTRIC CANCER)CDH1
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. CDH1 MLPA, BLOODCDMLPA
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. CEBPA, BLOODCEBPA
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. CEBPA, NON-BLOODBMCEBP
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. CF POLY-T ANALYSIS, BLOODCFPT
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. CF POLY-T ANALYSIS, NON-BLOODNCFPT
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. CFTR DELETION/DUPLICATION ANALYSIS BY MLPACFMLPA
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. CFTR SCREEN BY SEQUENCINGCFSS
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. CONNEXIN 26 SEQUENCING, BLOODCX26S
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. CONNEXIN 26 SEQUENCING, NON-BLOODFCX26S
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. CONNEXIN 30, BLOODCX30
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. CONNEXIN 30, NON-BLOODNCX30
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. CYSTIC FIBROSIS DIAGNOSTIC SEQUENCING ASSAY, BLOODCFDS
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. CYSTIC FIBROSIS DIAGNOSTIC SEQUENCING ASSAY, NON-BLOODNCFDS
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. CYSTIC FIBROSIS MUTATION STUDY (CF), BLOODCF32
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. CYSTIC FIBROSIS MUTATION STUDY (CF), NON BLOODNCF32
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. DUCHENNE AND BECKER MUSCULAR DYSTROPHIES BY MLPADBMLPA
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. EGFR, BLOODEGFR
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. EGFR, NON-BLOODNEGFR
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. FACTOR V LEIDEN, BLOODLEID
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. FGFR1 CRANIOSYNOSTOSIS, BLOODFGFR1
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. FGFR1 CRANIOSYNOSTOSIS, NON-BLOODFFGFR1
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. FGFR2 CRANIOSYNOSTOSIS, BLOODFGFR2
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. FGFR2 CRANIOSYNOSTOSIS, NON-BLOODFFGFR2
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. FGFR3 MUENKE, BLOODFGFR3
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. FGFR3 MUENKE, NON-BLOODFFGFR3
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. FRAGILE XFRAGX
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. HEMOCHROMATOSIS GENOTYPING ASSAYHCHGA
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. HUNTINGTON'S DISEASE ANALYSIS BY PCRHUNT
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. JANUS KINASE 2 V617F MUTATION, BLOODJAK2
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. JANUS KINASE 2 V617F MUTATION, NON-BLOODNJAK2
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. KIT D816V MUTATION BY AS-PCR, BLOODD816V
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. KIT D816V MUTATION BY AS-PCR, NON-BLOODND816V
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. KIT SEQUENCING (EXONS 8 AND 17), BLOODCKITMU
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. KIT SEQUENCING (EXONS 8 AND 17), NON-BLOODNCKIT
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. KRAS / NRAS MUTATION ANALYSISRAS
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. MATERNAL CELL CONTAMINATION, FETAL SAMPLEFMCC
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. MATERNAL CELL CONTAMINATION, MATERNAL SAMPLEMCC
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. MGMT PROMOTER METHYLATION, BLOODMGMTB
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. MGMT PROMOTER METHYLATION, NON-BLOODMGMT
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. MICROSATELLITE INSTABILITYTMSI
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. MYD88 MUTATION ANALYSIS, BLOODMYD88
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. MYD88 MUTATION ANALYSIS, NON BLOODNMYD88
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. PENDRED SYNDROME, BLOODPDS
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. PENDRED SYNDROME, NON-BLOODNPDS
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. PML/RARA, QUANTITATIVE, BLOODT1517
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. PML/RARA, QUANTITATIVE, NON-BLOODBM1517
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. PRADER-WILLI SYNDROMEPWS
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. PROTHROMBIN-20210A MUTATION, BLOODP20210
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. SF3B1 BY SEQUENCING, BLOODSF3B1
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. SF3B1 BY SEQUENCING, NON-BLOODNSF3B1
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. STANFORD SOLID TUMOR ACTIONABLE MUTATION PANELSTAMP
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. T-CELL CLONALITY BY PCR REFLEX TO TCR-BETA (TCRB) REARRANGEMENTS, BLOODTCLON
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. T-CELL CLONALITY BY PCR REFLEX TO TCR-BETA (TCRB) REARRANGEMENTS, NON-BLOODBMTCLO
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. VH HYPERMUTATION, BLOODVHHA
Molecular Genetic Pathology Laboratory includes diagnostic services for inherited genetic disorders, hematolymphoid malignancies, solid tumors, and genetic risk factors. VH HYPERMUTATION, NON-BLOODNVHHA
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisUNFRACTIONATED HEPARIN ACTIVITY BY ANTI-Xa ACTIVITYHEPAR85520
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisACTIVATED PROTEIN C RESISTANCEAPC
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisADAMTS-13 PROFILEADAMTS
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisANTI-PHOSPHOLIPID ANTIBODY PANELAPHSA2
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisANTI-THROMBIN III PLASMAAT3
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisBETA-2 GLYCOPROTEIN 1B2GP1
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisCARDIOLIPIN ANTIBODY, IGG AND IGM, SERUMACA
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisD-DIMER (ELISA)DDIML
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisD-DIMER PLASMA, QUALITATIVEDDIM
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisDILUTE RUSSELL VIPER VENOMDRVVTP
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisEUGLOBULIN CLOT LYSISECL
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisFACTOR II ASSAYFACT2
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisFACTOR IX ASSAYFACT9
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisFACTOR V ASSAYFACT5
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisFACTOR VII ASSAYFACT7
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisFACTOR VIII ASSAYFACT8
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisFACTOR VIII INHIBITOR, HUMANF8INH
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisFACTOR X ASSAYFACT10
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisFACTOR XI ASSAYFACT11
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisFACTOR XII ASSAYFACT12
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisFACTOR XIII SCREENFACT13
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisFIBRIN DEGRADATION PRODUCTSFDP
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisFREE PROTEIN S ACTIVITY, PLASMAPROTSF
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisHEPARIN PLATELET FACTOR 4 ANTIBODYHITAB
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisHEPARIN X A (FONDAPARINUX), PLASMAARIX
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisHIT FUNCTIONAL BY IMPEDANCE AGGREGOMETRYHITIA
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisLMWH ACTIVITY BY ANTI-Xa ACTIVITYANTIXA
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisLUPUS ANTICOAGULANT - PTTLALUPUS
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisPHOSPHATIDYLSERINE/PROTHROMBIN ANTIBODIESLABAPSPT
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisPLASMINOGEN ACTIVITYPLASMN
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisPLATELET AGGREGATIONPLTAGG
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisPLATELET FUNCTION SCREENPLTFUN
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisPLATELET INHIBITION BY THROMBOELASTOGRAPHY PLATELET MAPPINGPLTMAP
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisPROTEIN C ANTIGEN, TOTALTOTALC
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisPROTEIN C, ACTIVITY, PLASMAPROTC
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisPROTEIN S ANTIGEN, TOTALTOTALS
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisPROTEIN S, ACTIVITY, PLASMAPROTS
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisPT INHIBITOR SCREENPTINH
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisPTT INHIBITOR SCREENPTTINH
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisREPTILASE TIMEREPT
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisRISTOCETIN-INDUCED PLATELET AGGREGATIONRIPA
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisTHROMBIN TIMETT
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisVON WILLEBRAND DISEASE SCREENVWSCN
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisVON WILLEBRAND FACTOR ACTIVITYVWACT
Coagulation and Hemostasis Laboratory typically includes clinical and laboratory evaluation of disorders of hemostasis and thrombosisVON WILLEBRAND FACTOR ANTIGEN PLASMAVWAG
Flow Cytometry includes diagnostic test menu, including leukemia/lymphoma immunophenotyping, CD34+ stem cell quantitation, lymphocyte subset analysis, paroxysmal nocturnal hemoglobulinuria (PNH) screen and Sézary syndromeCD34 PANEL, BLOODCD3486367
Flow Cytometry includes diagnostic test menu, including leukemia/lymphoma immunophenotyping, CD34+ stem cell quantitation, lymphocyte subset analysis, paroxysmal nocturnal hemoglobulinuria (PNH) screen and Sézary syndromeCD34 PANEL, BONE MARROWBMCD34
Flow Cytometry includes diagnostic test menu, including leukemia/lymphoma immunophenotyping, CD34+ stem cell quantitation, lymphocyte subset analysis, paroxysmal nocturnal hemoglobulinuria (PNH) screen and Sézary syndromeCD34 PANEL, FLUIDFCD34
Flow Cytometry includes diagnostic test menu, including leukemia/lymphoma immunophenotyping, CD34+ stem cell quantitation, lymphocyte subset analysis, paroxysmal nocturnal hemoglobulinuria (PNH) screen and Sézary syndromeCD4-CD8 PANEL, BLOODC4C8
Flow Cytometry includes diagnostic test menu, including leukemia/lymphoma immunophenotyping, CD34+ stem cell quantitation, lymphocyte subset analysis, paroxysmal nocturnal hemoglobulinuria (PNH) screen and Sézary syndromeEMA (EOSIN-5-MALEIMIDE) BY FLOW CYTOMETRYEMA
Flow Cytometry includes diagnostic test menu, including leukemia/lymphoma immunophenotyping, CD34+ stem cell quantitation, lymphocyte subset analysis, paroxysmal nocturnal hemoglobulinuria (PNH) screen and Sézary syndromeIMMUNOPHENOTYPING BY FLOW CYTOMETRYFCPATH
Flow Cytometry includes diagnostic test menu, including leukemia/lymphoma immunophenotyping, CD34+ stem cell quantitation, lymphocyte subset analysis, paroxysmal nocturnal hemoglobulinuria (PNH) screen and Sézary syndromePAROXYSMAL NOCTURNAL HEMOGLOBINURIA SCREEN (PNH) SCREEN PATH13/FCPATHPATH13/FCPATH
Flow Cytometry includes diagnostic test menu, including leukemia/lymphoma immunophenotyping, CD34+ stem cell quantitation, lymphocyte subset analysis, paroxysmal nocturnal hemoglobulinuria (PNH) screen and Sézary syndromeSÉZARY/T-CELL PANELPATH18
Flow Cytometry includes diagnostic test menu, including leukemia/lymphoma immunophenotyping, CD34+ stem cell quantitation, lymphocyte subset analysis, paroxysmal nocturnal hemoglobulinuria (PNH) screen and Sézary syndromeT SUBSETS AND B LYMPHS, FLUIDFTBLYM
Flow Cytometry includes diagnostic test menu, including leukemia/lymphoma immunophenotyping, CD34+ stem cell quantitation, lymphocyte subset analysis, paroxysmal nocturnal hemoglobulinuria (PNH) screen and Sézary syndromeT SUBSETS AND B LYMPHS, WHOLE BLOODTBLYM
[/fusion_text]

(Visited 53 times, 1 visits today)
Share